Stay updated on Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, reflecting a minor platform/version change without altering the displayed trial details.
    Difference
    0.0%
    Check dated 2026-04-25T18:25:24.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.0.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:17:51.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Location entry updated from Napoli, Italy, 80123 to Naples, Italy, 80123. Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T19:51:48.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:20:10.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    New registry identifiers UTN and EU CT were added and old registry references updated. The page now includes links for trial transparency data sharing (trialstransparency PDF) and external data sharing site.
    Difference
    0.3%
    Check dated 2026-02-20T17:14:56.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T12:51:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.